These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 21597710)

  • 1. Pathological-changes of the blood-cells in griseofulvin treated toads.
    Elmofty M; Abdelmeguid N; Essawy A
    Oncol Rep; 1995 Jan; 2(1):167-70. PubMed ID: 21597710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of toads (Bufo regularis) in a new biological assay for screening chemicals or drugs which induce leukaemia in man.
    Elmofty M; Abdelmeguid N; Sadek I; Essawy A; Abdelaleem E
    Oncol Rep; 1997; 4(3):657-60. PubMed ID: 21590119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topically applied griseofulvin in prevention and treatment of Trichophyton mentagrophytes.
    Epstein WL; Shah VP; Jones HE; Riegelman S
    Arch Dermatol; 1975 Oct; 111(10):1293-7. PubMed ID: 1103743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Griseofulvin].
    Develoux M
    Ann Dermatol Venereol; 2001 Dec; 128(12):1317-25. PubMed ID: 11908134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The systemic treatment of onychomycosis.
    Wenig JA
    Clin Podiatr Med Surg; 1995 Apr; 12(2):263-74. PubMed ID: 7600500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of leukaemia in chloramphenicol-treated toads.
    el-Mofty MM; Abdelmeguid NE; Sadek IA; Essawy AE; Aleem EA
    East Mediterr Health J; 2000; 6(5-6):1026-34. PubMed ID: 12197324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of 1,2-Dihydro-2,2,4-Trimethylquinoline (CAS No. 147-47-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies) and the Dermal Initiation/Promotion Study in Female Sencar Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Feb; 456():1-312. PubMed ID: 12587020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bioavailability of anhydrous griseofulvin and its chloroform solvate in man.
    Bates TR; Fung HL; Lee H; Tembo AV
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):233-43. PubMed ID: 1153870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungal nail infections: diagnosis and management.
    Prescrire Int; 2009 Feb; 18(99):26-30. PubMed ID: 19391293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro/in vivo phototoxic risk assessments of griseofulvin based on photobiochemical and pharmacokinetic behaviors.
    Seto Y; Onoue S; Yamada S
    Eur J Pharm Sci; 2009 Sep; 38(2):104-11. PubMed ID: 19576281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial fungal infections in children and adolescents.
    Rudy SJ
    Nurse Pract Forum; 1999 Jun; 10(2):56-66. PubMed ID: 10542582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis.
    Cole GW; Stricklin G
    Arch Dermatol; 1989 Nov; 125(11):1537-9. PubMed ID: 2684023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of topical griseofulvin in treatment of tinea corporis.
    Kassem MA; Esmat S; Bendas ER; El-Komy MH
    Mycoses; 2006 May; 49(3):232-5. PubMed ID: 16681816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials.
    Fleece D; Gaughan JP; Aronoff SC
    Pediatrics; 2004 Nov; 114(5):1312-5. PubMed ID: 15520113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole.
    Dastghaib L; Azizzadeh M; Jafari P
    J Dermatolog Treat; 2005 Feb; 16(1):43-6. PubMed ID: 15897167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states.
    Ahmed IS; Aboul-Einien MH; Mohamed OH; Farid SF
    Eur J Pharm Sci; 2008 Oct; 35(3):219-25. PubMed ID: 18675344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte mitochondrial alterations in griseofulvin fed mice.
    Shapiro SH; Wessely Z; Klavins JV
    Ann Clin Lab Sci; 1980; 10(1):45-33. PubMed ID: 7362197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral griseofulvin in superficial fungal diseases of the skin. II. Treatment of fungal conditions with griseofulvin, scientific background.
    FRIEDMAN L
    J La State Med Soc; 1961 Jun; 113():231-4. PubMed ID: 13702017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.